Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.

Saved in:
Bibliographic Details
Title: Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma.
Authors: Landgren O; Sylvester Comprehensive Cancer Center, Myeloma Division University of Miami Miami Florida USA., Biran N; Hackensack University Medical Center Hackensack New Jersey USA., O'Donnell EK; Massachusetts General Hospital Cancer Center Boston Massachusetts USA., Mikhael J; Clinical Genomics and Therapeutics, City of Hope Cancer Center Translational Genomics Research Institute Phoenix Arizona USA., Weisel KC; Department of Oncology, Hematology and BMT University Medical Center of Hamburg-Eppendorf Hamburg Germany., Broijl A; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Usmani SZ; Myeloma Service, Division of Hematologic Oncology, Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA., Moreau P; Hematology Department CHU Nantes Nantes France., Gay FM; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy., Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy., Rodríguez-Otero P; Cancer Center Clínica Universidad de Navarra Pamplona Navarra Spain., Jakubowiak AJ; Section of Hematology/Oncology University of Chicago Chicago Illinois USA., Derman BA; Section of Hematology/Oncology University of Chicago Chicago Illinois USA.
Source: HemaSphere [Hemasphere] 2025 Jul 16; Vol. 9 (7), pp. e70178. Date of Electronic Publication: 2025 Jul 16 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2572-9241
DOI:10.1002/hem3.70178